WebMar 20, 2024 · BioNTech will pay OncoC4 $200 million up front and get global rights to its drug. Privately held OncoC4 could earn milestone payments, plus royalties if the research leads to a commercialized product. WebJun 14, 2024 · Uğur Şahin arrives at BioNTech’s headquarters in the German city of Mainz on the same battered bicycle he has been riding for 20 years. Developing the best-selling Covid-19 vaccine may have ...
BNTX.O - Stock Price & Latest News Reuters
WebTherapeutic Areas. We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer, and infectious diseases and other serious … WebFind the latest BioNTech SE (22UA.F) stock quote, history, news and other vital information to help you with your stock trading and investing. portland teardrop
What Drove BioNTech Stock’s Incredible Rise From $80 …
WebApr 3, 2024 · BioNTech ( NASDAQ: BNTX) signed a licensing agreement with Duality Biologics (Suzhou) (DualityBio) for two antibody-drug conjugate (ADC) assets for solid tumors. Under the agreements, DualityBio ... WebJul 23, 2024 · BIONTECH SE . Rights Offering for up to 7,505,596 Ordinary Shares Including Ordinary Shares Represented by American Depositary Shares . This Prospectus Supplement No. 3 supplements information contained in our prospectus, dated July 23, 2024, relating to the offering to holders of our ordinary shares and American Depositary … WebJan 10, 2024 · BioNTech SE has agreed to acquire British artificial intelligence (AI) startup InstaDeep for up to 562 million pounds ($682 million) to speed up its biotech research and manufacturing capabilities. portland team building events